Copeptin for the Prediction of Recurrent Cerebrovascular Events After Transient Ischemic Attack: Results From the CoRisk Study [Clinical Sciences]

Conclusions— Copeptin improved the prognostic value of the ABCD2 score for the prediction of stroke but not TIA, and it may help clinicians in refining risk stratification for patients with TIA. Clinical Trial Registration— URL: http://www.clinicaltrials.gov. Unique identifier: NCT00878813.

http://stroke.ahajournals.org/cgi/content/short/45/10/2918?rss=1

Source: Stroke - September 22, 2014 Category: Neurology Authors: De Marchis, G. M., Weck, A., Audebert, H., Benik, S., Foerch, C., Buhl, D., Schuetz, P., Jung, S., Seiler, M., Morgenthaler, N. G., Mattle, H. P., Mueller, B., Christ-Crain, M., Arnold, M., Katan, M. Tags: Acute Cerebral Infarction, Emergency treatment of Stroke Clinical Sciences Source Type: research